An alternative and scalable synthesis for Relugolix

被引:0
|
作者
Wang, Xuan [1 ]
Luo, Ying [1 ]
Zhang, Peng [1 ]
Zhu, Xueyan [1 ]
Liu, Xiangkui [1 ]
Chen, Yinbo [1 ]
机构
[1] Shanghai Inst Pharmaceut Ind Co Ltd, China State Inst Pharmaceut Ind Co Ltd, 285 Gebaini Rd, Shanghai 201203, Peoples R China
关键词
Relugolix; New synthetic route; Optimization; Scale up;
D O I
10.1016/j.tet.2024.134243
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
An alternative and efficient synthetic route for Relugolix was accomplished by changing the construction order of three main parts A, B and C. After the optimization, its scale-up of the preparation for Relogulix was completed in a seven-step methodology with overall yield of 61 % and 99.62 % HPLC purity.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] An Alternative Scalable Process for the Synthesis of the Key Intermediate of Omarigliptin
    Sun, Guodong
    Wei, Mingjie
    Luo, Zhonghua
    Liu, Yongjun
    Chen, Zhijun
    Wang, Zhongqing
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2016, 20 (12) : 2074 - 2079
  • [2] Relugolix
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (09) : 762 - 763
  • [3] An Alternative Scalable Process for the Synthesis of 4,6-Dichloropyrimidine-5-carbonitrile
    Zhang, Bin
    Yan, Huixin
    Ge, Chongfeng
    Liu, Bo
    Wu, Zhenping
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (12) : 1733 - 1737
  • [4] The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial
    Naoki Kawahara
    Ryuji Kawaguchi
    Konosuke Yamamoto
    Kyohei Nishikawa
    Motoki Matsuoka
    Tomoka Maehana
    Yosuke Fukui
    Shoichiro Yamanaka
    Sumire Sugimoto
    Kana Iwai
    Yuki Yamada
    Hiroyuki Kurakami
    Takumi Hirata
    Ryuzo Takashima
    Shota Suzuki
    Kiyoshi Asada
    Masato Kasahara
    Fuminori Kimura
    Trials, 25
  • [5] The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial
    Kawahara, Naoki
    Kawaguchi, Ryuji
    Yamamoto, Konosuke
    Nishikawa, Kyohei
    Matsuoka, Motoki
    Maehana, Tomoka
    Fukui, Yosuke
    Yamanaka, Shoichiro
    Sugimoto, Sumire
    Iwai, Kana
    Yamada, Yuki
    Kurakami, Hiroyuki
    Hirata, Takumi
    Takashima, Ryuzo
    Suzuki, Shota
    Asada, Kiyoshi
    Kasahara, Masato
    Kimura, Fuminori
    TRIALS, 2024, 25 (01)
  • [6] Scalable Synthesis of a Ruthenium-Based Electrocatalyst as a Promising Alternative to Pt for Hydrogen Evolution Reaction
    Zhang, Zhen
    Li, Ping
    Feng, Qi
    Wei, Bing
    Deng, Chenglong
    Fan, Jiantao
    Li, Hui
    Wang, Haijiang
    ACS APPLIED MATERIALS & INTERFACES, 2018, 10 (38) : 32171 - 32179
  • [7] Synthetic Process of Relugolix
    Li, Min
    Hong, Bibo
    Chen, Yinbo
    Hu, Liang
    Liu, Xiangkui
    Chinese Journal of Pharmaceuticals, 2022, 53 (07): : 962 - 968
  • [8] Scalable Synthesis Technology
    Wenter, Philipp
    AMERICAN LABORATORY, 2017, 49 (05) : 31 - 31
  • [9] Scalable synthesis of cladosporin
    Das, Pronay
    Mankad, Yash
    Reddy, D. Srinivasa
    TETRAHEDRON LETTERS, 2019, 60 (12) : 831 - 833
  • [10] Scalable Synthesis of (-)-Thapsigargin
    Chu, Hang
    Smith, Joel M.
    Felding, Jakob
    Baran, Phil S.
    ACS CENTRAL SCIENCE, 2017, 3 (01) : 47 - 51